Cure My Disease

Don't miss your cure!

 Log in / Sign up

Pen and paper: a new weapon against blood cancer stress?

NCT ID NCT07413991

Recruiting now Symptom relief Sponsor: Blood Cancer United Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study explores whether an online expressive writing workshop can boost mental wellness in young adults (ages 18-39) with blood cancer. One hundred participants will either start the workshop right away or wait four weeks. Everyone takes surveys about their mood and stress over 12 weeks. The goal is to see if writing about emotions can make a real difference.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Expressive Writing Workshop
What this could lead to
If it works, this could offer a simple, low-cost way to help young adults with blood cancer feel better emotionally.
What could go wrong
This is a small, early-stage study with only 100 participants. The workshop may not lead to lasting improvements in mental wellness, and results may not apply to everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEMATOLOGIC MALIGNANCY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hematopoietic and lymphoid cell neoplasm hematopoietic and lymphoid system neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEMATOLOGIC MALIGNANCY

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Blood Cancer United

    RECRUITING

    Washington D.C., District of Columbia, 20005, United States

    Contact Phone: •••-•••-••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.